Tokyo, Japan

Shinko Hayashi

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Daiichi Sankyo Company, Limited, Daiichi Sankyo Europe Gmbh. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinko Hayashi. Retrieved from https://idiyas.com/inventor/shinko-hayashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shinko Hayashi: Innovator in Antibody Development

Introduction

Shinko Hayashi is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of biotechnology, particularly in the development of novel antibodies.

Latest Patents

Hayashi holds a patent for a Human anti-FGFR4 antibody. This invention relates to innovative antibodies against the FGF receptor 4 (FGFR4) and their medical applications. The patent focuses on the diagnosis, prevention, or treatment of diseases associated with FGFR expression, overexpression, or hyperactivity. He has 1 patent to his name.

Career Highlights

Throughout his career, Shinko Hayashi has worked with notable companies in the pharmaceutical industry. He has been associated with Daiichi Sankyo Europe GmbH and Daiichi Sankyo Company, Limited. His work in these organizations has contributed to advancements in medical research and therapeutic development.

Collaborations

Hayashi has collaborated with esteemed colleagues, including Reimar Abraham and Keisuke Fukuchi. These partnerships have fostered innovation and progress in their respective fields.

Conclusion

Shinko Hayashi's work in antibody development showcases his dedication to advancing medical science. His contributions have the potential to impact the diagnosis and treatment of various diseases significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…